This company listing is no longer active
S2M BTU B Stock Overview
Develops, produces, and sells wound healing products for burns and chronic wounds in Sweden.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
S2Medical AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.073 |
| 52 Week High | kr0.15 |
| 52 Week Low | kr0.056 |
| Beta | 0.12 |
| 11 Month Change | -0.55% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -27.40% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| S2M BTU B | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 3.7% | -0.8% | 0.7% |
| 1Y | n/a | -0.8% | 16.6% |
Return vs Industry: Insufficient data to determine how S2M BTU B performed against the Swedish Medical Equipment industry.
Return vs Market: Insufficient data to determine how S2M BTU B performed against the Swedish Market.
Price Volatility
| S2M BTU B volatility | |
|---|---|
| S2M BTU B Average Weekly Movement | 20.1% |
| Medical Equipment Industry Average Movement | 7.1% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in SE Market | 12.8% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: S2M BTU B's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine S2M BTU B's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 20 | Petter Sivlér | www.s2m.se |
S2Medical AB (publ) develops, produces, and sells wound healing products for burns and chronic wounds in Sweden, Norway, and Denmark. It offers Epiprotect 2117, a synthetic allograft/xenograft substitute; Epiprotect Ulcer, a wound dressing consisting of a thin film of biosynthetic cellulose polymer intended to be used as a protective barrier for superficial wounds and deep wounds that have breached the dermis, as well as used as a temporary coverage for deep extensive wounds before transplantation or other surgical intervention. The company also provides washable, durable, waterproof, and self-adhesive bandages under the INSTABIND brand name, as well as NO SMELL, a perfume-free odour remover.
S2Medical AB (publ) Fundamentals Summary
| S2M BTU B fundamental statistics | |
|---|---|
| Market cap | kr7.80m |
| Earnings (TTM) | -kr26.45m |
| Revenue (TTM) | kr5.08m |
1.5x
P/S Ratio-0.3x
P/E RatioIs S2M BTU B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| S2M BTU B income statement (TTM) | |
|---|---|
| Revenue | kr5.08m |
| Cost of Revenue | -kr112.55k |
| Gross Profit | kr5.19m |
| Other Expenses | kr31.64m |
| Earnings | -kr26.45m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
Aug 25, 2023
| Earnings per share (EPS) | -0.81 |
| Gross Margin | 102.22% |
| Net Profit Margin | -521.18% |
| Debt/Equity Ratio | 0% |
How did S2M BTU B perform over the long term?
See historical performance and comparison